Read here for more on ClearPoint Neuro (CLPT) stock's Q2 performance, key catalysts like GLP services, and future growth ...

Fidus is a strong buy with resilient earnings, 10.5% dividend yield, and potential for growth amidst macro challenges. Read ...

Pebblebrook Hotel Trust (PEB) stock's preferred shares offer 8%+ yield, safety, and upside potential. Read here for an ...

The producer price index (PPI) for final demand rose 0.9% month-over-month after a flat reading in June. Core PPI, which ...

First Trust Cloud Computing ETF offers a balanced cloud computing exposure, blending mega caps and growth names. See more on ...

Pantheon Macroeconomics sees artificial intelligence as a growing force in U.S. economic expansion, with recent data pointing ...

Brazil Potash is in talks with banks and other lenders to secure $1.7B-$1.8B in debt to fund its planned potash mine in ...

Soroban Capital acquired new positions in Meta Platforms (META) and CDW (CDW), closed out its holdings in CoStar Group (CSGP) ...

The main advantage that Himalaya Shipping holds over other pure Capesize plays is the fact that the fleet consists entirely ...

I am reversing my rating on Akero Therapeutics stock from Buy to Sell due to valuation concerns and a long-ish wait for ...

E.ON's H1 2025 results reveal strong network EBITDA but weaker energy retail performance. Rising debt & regulatory risks ...

Billionaire Larry Robbins' Glenview Capital Management in Q2 took new stakes in several major companies, including Dick's ...